Skip to content

Clinical trials

Active, not recruiting Breast Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Active, not recruiting Country / region: Belgium Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20144
20152
20161
20172
20183
20194
20207
202112
20228
20236
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Eli Lilly and Company9
Hoffmann-La Roche6
Pfizer3
European Organisation for Research and Treatment of Cancer - EORTC2
Jules Bordet Institute2
Novartis Pharmaceuticals2
Seagen, a wholly owned subsidiary of Pfizer2
Universitair Ziekenhuis Brussel2
Actuate Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms57
Neoplasm Metastasis10
Neoplasms4
Breast Diseases3
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Sarcoma3
Triple Negative Breast Neoplasms3
Brain Neoplasms2
Chronic Pain2

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.